Pharmafile Logo

patient expectations

- PMLiVE

The long and winding road to asthma breakthroughs

Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks

- PMLiVE

OPEN Health expands global footprint with Pharmerit International integration

Global health comms and market access group now has presence in six countries

- PMLiVE

Takeda’s dengue vaccine seems safe with no prior virus exposure

Appears unaffected by serious safety issue affecting Sanofi rival

- PMLiVE

NICE International relaunches, will offer advisory services

Meets growing demand from global health and social care organisations

- PMLiVE

Indegene Pharma Marketer 2020 Report predicts significant shift in channel spends

Content personalisation to continue to yield disproportionate returns

- PMLiVE

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Will pay $100m upfont and pledges $210m in milestone payments

- PMLiVE

W2O continues global expansion with ISO.health acquisition

Acquisition of London-based agency extends reach into Europe

- PMLiVE

Evotec and Vifor announce joint venture for kidney disease treatments

Both companies will split the clinical and commercial costs equally

Patient journey mapping: exploring the clinical and the emotional journey

By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew

- PMLiVE

Rewarding Long Service at Bedrock

Katie Penfold celebrates 5 years with the Bedrock Group

Bedrock Healthcare Communications

- PMLiVE

Restoring Equilibrium at Lucid Group

It’s National Stress Awareness Day, which is a great opportunity to take a moment to think about our wellbeing. This time of year is often busier than normal. At Lucid,...

Lucid Group Communications Limited

- PMLiVE

Takeda divests over-the-counter and prescription drugs to Stada for $660m

Japanese pharma said it has plans to divest $10bn in non-core assests

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links